Clinical Trial Update: (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets [Phase 3]

View source ↗

Summary

Phase 3 trial results for oral budesonide-MMX 9mg extended-release tablets in ulcerative colitis have been completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide-MMX 9 mg (budesonide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05